Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination

Area of Science:

• Neuroscience
• Endocrinology
• Immunology

Background:

• Multiple sclerosis (MS) involves myelin destruction and axonal degeneration in the central nervous system (CNS).
• Current MS therapies primarily target immune modulation, showing limited efficacy in progressive forms where neurodegeneration dominates.
• Remyelination, driven by oligodendrocyte precursor cells (OPCs), offers a potential therapeutic strategy for progressive MS.

Purpose of the Study:

• To review the positive effects of remyelination on MS.
• To explore the critical role of thyroid hormone (TH) in promoting remyelination.
• To hypothesize the mechanism by which TH alleviates MS through remyelination.

Main Methods:

• Literature review focusing on thyroid hormone's role in remyelination.
• Analysis of TH's effects on OPCs and gene transcription.
• Development of a working hypothesis on TH's therapeutic potential in MS.

Main Results:

• Thyroid hormone (TH) demonstrates promising therapeutic potential for MS by targeting remyelination.
• TH actively promotes remyelination and regulates endogenous stem and precursor cells.
• TH influences gene transcription, suggesting a mechanistic pathway for its effects.

Conclusions:

• TH can alleviate multiple sclerosis (MS) by promoting remyelination.
• The mechanism involves TH's regulatory role in the gene transcription of oligodendrocyte precursor cells (OPCs).
• Targeting TH-induced remyelination presents a novel therapeutic avenue for progressive MS.